Pharmalot By Ed Silverman Pharmalittle: Pharma lobbies Congress on global tax proposal; the FDA doc at center of Aduhelm controversy
Pharmalot By Ed Silverman Pharmalittle: A race to develop Covid-19 pills is underway; Russian trolls target Pfizer vaccine
Pharmalot By Ed Silverman Pharmalittle: Biogen defends its controversial Alzheimer’s drug; critics pan Pfizer plan for Covid-19 shot production in Africa
Pharmalot By Ed Silverman Pharmalittle: Pfizer cuts deal for Covid-19 shot to be partially made in South Africa; wholesalers to pay $1.1b to NY to settle opioid suit
Pharmalot By Ed Silverman Pharmalittle: Pfizer seeks full FDA approval for its Covid-19 vaccine; CT attorney general calls some Sacklers ‘entitled thugs’
Pharmalot By Ed Silverman Pharmalittle: Lilly seeks speedy U.S. approval for its Alzheimer’s drug; FDA’s Woodcock ‘not concerned’ about criticism
Pharmalot By Elizabeth Cooney Pharmalittle: How Pfizer’s Covid vaccine boxes complicated rollout; FDA and J&J near deal to reopen vaccine plant
Pharmalot By Ed Silverman Pharmalittle: Russia’s Covid-19 vaccine appears effective; BioCryst stock is pursued by Reddit investors
Pharmalot By Ed Silverman Pharmalittle: Francis Collins to step down as NIH director; Research confirms decline in Pfizer vaccine protection against ‘breakthrough’ infection
Pharmalot By Ed Silverman Pharmalittle: J&J to seek emergency use of Covid-19 vaccine booster; Pfizer loses legal battle over Medicare co-pay programs
Pharmalot By Ed Silverman Pharmalittle: CDC director overrules panel and recommends Pfizer shot for at-risk workers; DOD watchdog faults military over pharma supply chain issues
Pharmalot By Ed Silverman Pharmalittle: Biogen yanks Alzheimer’s paper from JAMA over edits; Pfizer sees $33.5 billion in Covid-19 vax sales
Pharmalot By Elizabeth Cooney Pharmalittle: Biogen’s ‘symptom quiz’ for Aduhelm draws fire; most U.S. clinical trials flunk transparency rules
Pharmalot By Elizabeth Cooney Pharmalittle: Inside the FDA’s contentious Aduhelm approval; Peter Bach heading to liquid biopsy startup
Pharmalot By Ed Silverman Pharmalittle: AstraZeneca may have used ‘outdated’ info about its Covid-19 shot; Democrats eye drug-pricing measures
Pharmalot By Ed Silverman Pharmalittle: U.S. sits on millions of AstraZeneca vaccine doses; WTO again fails to act on Covid-19 proposal
Pharmalot By Ed Silverman Pharmalittle: Lilly fired manager who tracked employee production complaints; Denmark suspends AstraZeneca shot
Pharmalot By Ed Silverman Pharmalittle: Covid-19 forces FDA to postpone inspections; pharma urges Biden to reject WTO proposal
Pharmalot By Ed Silverman Pharmalittle: Merck says early data shows pill is effective against Covid-19; WHO’s COVAX program ships first doses
Pharmalot By Damian Garde Pharmalittle: Sarepta wins another FDA nod; Germans balk at AstraZeneca vaccine
Pharmalot By Ed Silverman Pharmalittle: House Dems slip drug pricing proposal into Covid-19 relief bill; FDA grants emergency use for Lilly drug
Pharmalot By Ed Silverman Pharmalittle: GSK to partner with CureVac on Covid-19 vaccine; Jazz to buy GW Pharma in $7.2 billion deal
Pharmalot By Ed Silverman Pharmalittle: FDA finds Moderna vaccine effective; Trump drug discount card gets new life
Pharmalot By Damian Garde Pharmalittle: Operation Warp Speed is more Army than science; J&J’s Covid-19 vaccine moves forward
Pharmalot By Ed Silverman Pharmalittle: In political ploy, Trump promises drug coupons to seniors; N.Y. plans its own Covid-19 vaccine reviews
Pharmalot By Ed Silverman Pharmalittle: Trump may not approve FDA emergency use guidelines; U.K. starts world’s first Covid-19 challenge trial
Pharmalot By Elizabeth Cooney Pharmalittle: Slaoui vows to quit OWS if politics trumps vaccine science; do we have enough freezers?
Pharmalot By Damian Garde Pharmalittle: Trump promises a Covid-19 vaccine in 2020; WHO’s grand experiment is faltering
Pharmalot By Ed Silverman Pharmalittle: Lilly starts late-stage trial of Covid-19 antibody; concern grows over political intervention on Covid-19 vaccine
Pharmalot By Ed Silverman Pharmalittle: Trump officials maintain Covid-19 vaccine won’t be influenced by politics; Novartis pays $678 million to settle kickback charges
Pharmalot By Ed Silverman Pharmalittle: Groups backed by pharma oppose equitable Covid-19 pricing; AstraZeneca strikes big Covid-19 vaccine deal
Pharmalot By Ed Silverman Pharmalittle: France piles pressure on Sanofi over Covid-19 vaccine; GOP fails to land a punch on Bright
Pharmalot By Ed Silverman Pharmalittle: Thousands sign up for trials studying hydroxycholoroquine; Gilead drug fails to help Covid-19 patients